Eva Malířová

497 total citations
29 papers, 393 citations indexed

About

Eva Malířová is a scholar working on Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eva Malířová has authored 29 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eva Malířová's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Retinoids in leukemia and cellular processes (3 papers). Eva Malířová is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Retinoids in leukemia and cellular processes (3 papers). Eva Malířová collaborates with scholars based in Czechia, Germany and Slovenia. Eva Malířová's co-authors include Bohuslav Melichar, Dagmar Solichová, J Horáček, J Malý, J Vizdá, Hana Kalábová, Miroslav Solař, Jiří Ceral, Z Zadák and Lenka Kujovská Krčmová and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Endocrinology and Supportive Care in Cancer.

In The Last Decade

Eva Malířová

28 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Malířová Czechia 12 146 98 73 63 62 29 393
Adetola Daramola Nigeria 13 49 0.3× 133 1.4× 82 1.1× 43 0.7× 58 0.9× 51 459
Ning Ma China 11 63 0.4× 43 0.4× 153 2.1× 102 1.6× 32 0.5× 32 385
Alaa Sada United States 12 52 0.4× 94 1.0× 172 2.4× 87 1.4× 40 0.6× 40 469
R. Nishimura Japan 11 27 0.2× 85 0.9× 80 1.1× 99 1.6× 34 0.5× 34 351
Meizi Cui China 10 166 1.1× 53 0.5× 70 1.0× 145 2.3× 85 1.4× 11 527
Kyoko Furuta Japan 11 84 0.6× 32 0.3× 44 0.6× 80 1.3× 57 0.9× 20 370
Chu Chen United States 10 34 0.2× 72 0.7× 78 1.1× 175 2.8× 81 1.3× 15 453
Xiaolong Yu China 14 63 0.4× 62 0.6× 69 0.9× 122 1.9× 27 0.4× 23 567
Claudia Huesca‐Gómez Mexico 12 90 0.6× 14 0.1× 96 1.3× 81 1.3× 65 1.0× 38 415
Y-T Gao United States 7 65 0.4× 142 1.4× 40 0.5× 89 1.4× 33 0.5× 8 383

Countries citing papers authored by Eva Malířová

Since Specialization
Citations

This map shows the geographic impact of Eva Malířová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Malířová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Malířová more than expected).

Fields of papers citing papers by Eva Malířová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Malířová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Malířová. The network helps show where Eva Malířová may publish in the future.

Co-authorship network of co-authors of Eva Malířová

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Malířová. A scholar is included among the top collaborators of Eva Malířová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Malířová. Eva Malířová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malíř, František, Vladimír Ostrý, Jakub Toman, et al.. (2019). Analyses of biomarkers of exposure to nephrotoxic mycotoxins in a cohort of patients with renal tumours. Mycotoxin Research. 35(4). 391–403. 28 indexed citations
2.
3.
Cwiertka, Karel, Hana Študentová, Č Neoral, et al.. (2012). Prognostic Significance of Serum Neopterin in Patients with Esophageal Carcinoma. SHILAP Revista de lepidopterología. 23(1). 22–26. 3 indexed citations
4.
Horáček, J, Roman Šafránek, Eva Malířová, et al.. (2012). Thyroid hormone abnormalities in haemodialyzed patients: low triiodothyronine as well as high reverse triiodothyronine are associated with increased mortality. 15th International & 14th European Congress of Endocrinology. 29. 2 indexed citations
5.
Melichar, Bohuslav, Pavlína Králíčková, Radomı́r Hyšpler, et al.. (2012). Hypomagnesaemia in patients with metastatic colorectal carcinoma treated with cetuximab.. PubMed. 59(114). 366–71. 10 indexed citations
6.
Solař, Miroslav, et al.. (2012). Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients. European Journal of Endocrinology. 166(4). 679–686. 26 indexed citations
7.
Horáček, J, et al.. (2010). Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. European Journal of Endocrinology. 163(4). 645–650. 104 indexed citations
8.
Beneš, Petr, et al.. (2009). Serum Neopterin in Patients with Malignant Melanoma. Pteridines. 20(1). 45–48. 1 indexed citations
9.
Melichar, Bohuslav, Hana Študentová, Eva Malířová, et al.. (2009). Serum Neopterin, Retinol and Alpha-tocopherol in Patients with the Carcinoma of the Esophagus. Pteridines. 20(1). 49–53. 1 indexed citations
10.
Solař, Miroslav, Jiří Ceral, Antonı́n Krajina, et al.. (2009). Adrenal Venous Sampling: Where Is the Aldosterone Disappearing to?. CardioVascular and Interventional Radiology. 33(4). 760–765. 13 indexed citations
11.
Melichar, Bohuslav, et al.. (2009). Repeat chemosensitivity of epithelial ovarian carcinoma in a BRCA1 mutation carrier to paclitaxel/platinum combination chemotherapy.. PubMed. 30(3). 323–5. 5 indexed citations
12.
Malířová, Eva, et al.. (2008). Cerebrospinal Fluid Neopterin in Patients with Tumors and other Disorders. Pteridines. 19(1). 86–91. 7 indexed citations
13.
Melichar, Bohuslav, Hana Kalábová, Lenka Kujovská Krčmová, et al.. (2008). Serum alpha-tocopherol, retinol and neopterin during paclitaxel/carboplatin chemotherapy.. PubMed. 27(6C). 4397–401. 13 indexed citations
14.
Melichar, Bohuslav, Hana Kalábová, Lubor Urbánek, Eva Malířová, & Dagmar Solichová. (2007). Serial Urinary Neopterin Measurements Reflect the Disease Course in Patients with Epithelial Ovarian Carcinoma Treated with Paclitaxel/Platinum Chemotherapy. Pteridines. 18(1). 1–7. 8 indexed citations
15.
Melichar, Bohuslav, et al.. (2006). Successful management of infusion reaction accompanying the start of cetuximab therapy. Supportive Care in Cancer. 15(4). 445–449. 21 indexed citations
16.
Melichar, Bohuslav, et al.. (2006). Urinary Neopterin in Patients with Advanced Colorectal Carcinoma. The International Journal of Biological Markers. 21(3). 190–198. 44 indexed citations
17.
Malířová, Eva, et al.. (2003). Deutsch-tschechisches Fehlerlexikon. 2 indexed citations
18.
Melichar, Bohuslav, František Malíř, Pavel Jandík, et al.. (1995). Increased urinary zinc excretion in cancer patients is linked to immune activation and renal tubular cell dysfunction. BioMetals. 8(3). 205–208. 13 indexed citations
19.
Melichar, Bohuslav, et al.. (1995). Gastric juice neopterin inHelicobacter pyloriinfection. FEMS Immunology & Medical Microbiology. 10(3-4). 335–338. 3 indexed citations
20.
Melichar, Bohuslav, et al.. (1994). Serum Neopterin and Angiotensin-converting Enzyme In Cancer Patients. Pteridines. 5(4). 133–135. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adetola Daramola Breakdown of academic impact, for papers by Ning Ma Breakdown of academic impact, for papers by Alaa Sada Breakdown of academic impact, for papers by R. Nishimura Breakdown of academic impact, for papers by Meizi Cui Breakdown of academic impact, for papers by Kyoko Furuta Breakdown of academic impact, for papers by Chu Chen Breakdown of academic impact, for papers by Xiaolong Yu Breakdown of academic impact, for papers by Claudia Huesca‐Gómez Breakdown of academic impact, for papers by Y-T Gao
Rankless by CCL
2026